Cencora Future Growth

Future criteria checks 2/6

Cencora is forecast to grow earnings and revenue by 8.5% and 6.1% per annum respectively. EPS is expected to grow by 11.3% per annum. Return on equity is forecast to be 76.5% in 3 years.

Key information

8.5%

Earnings growth rate

11.3%

EPS growth rate

Healthcare earnings growth	15.9%
Revenue growth rate	6.1%
Future return on equity	76.5%
Analyst coverage	Good
Last updated	01 May 2024

Recent future growth updates

Recent updates

Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings

Apr 05

Cencora Remains Chronically Undervalued, With Material Growth Potential

Mar 25

Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Mar 18

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Feb 25

Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Feb 07

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

Aug 01

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

Jul 28

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Jun 19

Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?

May 01

Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching

Apr 10

AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet

Mar 02

AmerisourceBergen declares $0.485 dividend

Feb 01

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Jan 28

AmerisourceBergen partners with pharmaceutical company Civica

Jan 23

AmerisourceBergen: What Does The Valuation Look Like After The Recent Price Rise?

Jan 13

Does AmerisourceBergen (NYSE:ABC) Deserve A Spot On Your Watchlist?

Jan 10

AmerisourceBergen sued by DoJ over suspicious opioid orders

Dec 29

Walgreens Boots Alliance sells $1.0B in AmerisourceBergen shares; $200M buyback from WBA

Dec 09

AmerisourceBergen's (NYSE:ABC) Upcoming Dividend Will Be Larger Than Last Year's

Nov 08

The Importance Of Government Contracting For AmerisourceBergen

Nov 02

Earnings and Revenue Growth Forecasts

NYSE:COR - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2026	328,614	2,420	3,023	3,593	13
9/30/2025	310,476	2,188	3,029	3,589	15
9/30/2024	291,398	2,013	2,494	2,901	14
3/31/2024	276,537	1,852	2,112	2,578	N/A
12/31/2023	271,579	1,867	3,630	4,086	N/A
9/30/2023	262,173	1,745	3,453	3,911	N/A
6/30/2023	254,425	1,689	2,793	3,249	N/A
3/31/2023	247,543	1,617	2,447	2,913	N/A
12/31/2022	241,805	1,729	2,057	2,550	N/A
9/30/2022	238,587	1,699	2,207	2,703	N/A
6/30/2022	236,325	1,842	2,061	2,548	N/A
3/31/2022	229,666	1,727	2,851	3,347	N/A
12/31/2021	221,101	1,614	2,174	2,627	N/A
9/30/2021	213,989	1,540	2,228	2,667	N/A
6/30/2021	204,321	-3,744	2,564	2,956	N/A
3/31/2021	196,282	-3,747	1,284	1,660	N/A
12/31/2020	194,546	-3,222	2,600	2,967	N/A
9/30/2020	189,894	-3,409	1,837	2,207	N/A
6/30/2020	186,287	1,570	1,250	1,581	N/A
3/31/2020	186,159	1,582	1,943	2,236	N/A
12/31/2019	182,061	649	1,710	2,008	N/A
9/30/2019	179,589	855	2,034	2,344	N/A
6/30/2019	177,248	956	2,018	2,337	N/A
3/31/2019	175,151	930	2,263	2,592	N/A
12/31/2018	172,866	1,190	1,538	1,880	N/A
9/30/2018	167,940	1,658	1,075	1,411	N/A
6/30/2018	163,763	1,081	1,783	2,126	N/A
3/31/2018	159,327	855	686	1,059	N/A
12/31/2017	155,441	979	N/A	1,945	N/A
9/30/2017	153,144	364	N/A	1,504	N/A
6/30/2017	151,584	855	N/A	1,478	N/A
3/31/2017	149,759	1,154	N/A	1,915	N/A
12/31/2016	148,310	1,346	N/A	1,997	N/A
9/30/2016	146,850	1,428	N/A	3,178	N/A
6/30/2016	144,759	1,643	N/A	2,986	N/A
3/31/2016	142,111	1,508	N/A	3,916	N/A
12/31/2015	139,082	391	N/A	3,777	N/A
9/30/2015	135,962	-138	N/A	3,922	N/A
6/30/2015	132,080	-431	N/A	3,591	N/A
3/31/2015	128,195	-658	N/A	2,989	N/A
12/31/2014	123,981	35	N/A	3,364	N/A
9/30/2014	119,569	282	N/A	1,465	N/A
6/30/2014	112,449	267	N/A	602	N/A
3/31/2014	104,008	344	N/A	157	N/A
12/31/2013	96,076	368	N/A	26	N/A
9/30/2013	87,959	493	N/A	788	N/A
6/30/2013	82,555	633	N/A	1,364	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: COR's forecast earnings growth (8.5% per year) is above the savings rate (2.4%).

Earnings vs Market: COR's earnings (8.5% per year) are forecast to grow slower than the US market (14.1% per year).

High Growth Earnings: COR's earnings are forecast to grow, but not significantly.

Revenue vs Market: COR's revenue (6.1% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: COR's revenue (6.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: COR's Return on Equity is forecast to be very high in 3 years time (76.5%).

Cencora Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Cencora, Inc. Reaffirms Guidance for Year 2024

Price target increased by 9.0% to US$235

Consensus EPS estimates fall by 14%

Recent updates

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Cencora, Inc. (NYSE:COR) announces an Equity Buyback for $2,000 million worth of its shares.

Executive VP & COO exercised options and sold US$4.9m worth of stock

Cencora, Inc. to Report Q2, 2024 Results on May 01, 2024

Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings

Cencora Remains Chronically Undervalued, With Material Growth Potential

Chairman exercised options and sold US$1.6m worth of stock

Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Cencora, Inc. Reaffirms Guidance for Year 2024

Cencora, Inc. Announces CEO Changes, Effective October 1, 2024

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Cencora’s FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products

Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

First quarter dividend of US$0.51 announced

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 9.0% to US$235

Consensus EPS estimates fall by 14%

Cencora, Inc. Declares Quarterly Cash Dividend on Common Share, Payable on February 26, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc. to Report Q1, 2024 Results on Jan 31, 2024

Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Cencora: Continued Economic Value On The Table Across All Investment Horizons

Chairman recently sold US$8.7m worth of stock

A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Chairman exercised options and sold US$3.1m worth of stock

Insider recently sold US$2.0m worth of stock

Executive VP & CFO exercised options and sold US$3.1m worth of stock

Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Cencora, Inc. Declares Quarterly Dividend, Payable November 27, 2023

Is Cencora (NYSE:COR) A Risky Investment?

Full year 2023 earnings: EPS misses analyst expectations

Cencora: New Name, Same Old Economic Leverage, Reiterate Buy

Chairman exercised options and sold US$2.7m worth of stock

Cencora, Inc. to Report Q4, 2023 Results on Nov 02, 2023

Insider exercised options and sold US$2.0m worth of stock

Now 20% undervalued after recent price drop

Chairman exercised options and sold US$1.0m worth of stock

Now 21% undervalued

Amerisourcebergen Corporation Elects Werner Baumann and Lauren Tyler to Its Board of Directors

Chairman notifies of intention to sell stock

AmerisourceBergen Corporation Declares Quarterly Cash Dividend, Payable on August 28, 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

Chairman notifies of intention to sell stock

AmerisourceBergen Corporation to Report Q3, 2023 Results on Aug 02, 2023

Insider exercised options and sold US$3.0m worth of stock

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Chairman exercised options and sold US$1.1m worth of stock

TPG Inc. (NasdaqGS:TPG), AmerisourceBergen Corporation (NYSE:ABC) and the management team of OneOncology, Inc. acquired OneOncology, LLC from General Atlantic Service Company, L.P. and others.

Executive VP & Chief Legal Officer recently sold US$731k worth of stock

Chairman exercised options and sold US$966k worth of stock

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?

Chairman notifies of intention to sell stock

Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching

Insider exercised options and sold US$54k worth of stock

Insider recently sold US$301k worth of stock

AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet

Chairman exercised options and sold US$858k worth of stock

Senior VP recently sold US$890k worth of stock

Senior VP exercised options and sold US$264k worth of stock

First quarter 2023 earnings: EPS misses analyst expectations

An unknown buyer acquired Brazil specialty business from AmerisourceBergen Corporation (NYSE:ABC).

AmerisourceBergen declares $0.485 dividend

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 25% Below Their Intrinsic Value Estimate

AmerisourceBergen Corporation, Annual General Meeting, Mar 09, 2023

AmerisourceBergen Corporation, Annual General Meeting, Mar 09, 2023

AmerisourceBergen partners with pharmaceutical company Civica

Chairman notifies of intention to sell stock

AmerisourceBergen: What Does The Valuation Look Like After The Recent Price Rise?